Many people believe that cancer is a metabolic disease. A biological process known as the mTOR pathway controls cellular metabolism by way of central signaling, and it is involved in […]
The existing drug development system “has failed miserably” for people with glioblastoma brain tumors, according to Al Musella, DPM, President of the Musella Foundation for Brain Tumor Research & Information, […]
Curious Dr. George Cancer Commons Contributing Editor George Lundberg, MD, is the face and curator of this invitation-only column. Richard B. Schwab, MD Professor of Medicine – Division of Hematology/Oncology; […]
Curious Dr. George Cancer Commons Contributing Editor George Lundberg, MD, is the face and curator of this invitation-only column. Marc B. Garnick, MD Gorman Brothers Professor of Medicine at Harvard […]
Curious Dr. George Cancer Commons Contributing Editor George Lundberg, MD, is the face and curator of this invitation-only column. Pauline Funchain, MD Director of the Melanoma Medical Oncology and Genomics Programs […]
Ryan Sullivan, MD Associate Director of the Melanoma Program at Massachusetts General Hospital Cancer Center, Associate Professor at Harvard Medical School Curious Dr. George Cancer Commons Contributing Editor George Lundberg, […]
Curious Dr. George Cancer Commons Contributing Editor George Lundberg, MD, is the face and curator of this invitation-only column. Lea Ann Browning-McNeeDirector of Communications & Stakeholder Engagement at the Reagan-Udall […]
For some people with glioblastoma brain tumors, enrolling in a clinical trial enables access to cutting-edge treatment. Here, our Curious Dr. George talks clinical trials with Cancer Commons Expert Physician […]
As a tumor grows, it may shed fragments of its DNA into the patient’s bloodstream. After treatment, if part of the tumor remains or it begins to grow again, […]